XML 74 R49.htm IDEA: XBRL DOCUMENT
v3.20.4

Collaboration Agreements (Research Collaborations and In-Licensing Arrangements) (Details) $ in Millions | 1 Months Ended | 9 Months Ended |
--- | --- | --- | ---
Jul. 31, 2019 USD ($) program | May 31, 2019 USD ($) | Oct. 02, 2020 USD ($) | Jan. 01, 2021 USD ($)
Collaborative Arrangement With Catalent |  |  |  |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |  |  |  |
Collaborative agreements upfront payments |  |  | $ 10.0 |
Collaboration and license agreement target selection term |  |  | 3 years |
Collaboration and license agreement extended target selection term |  |  | 5 years |
Collaboration agreements additional upfront payments |  |  | $ 4.0 |
Collaboration agreement option exercise fee payment, upon exercising option |  |  | 2.0 |
Maximum amount eligible for development and regulatory milestones |  |  | 44.0 |
Maximum amount eligible for commercial milestones under collaborations agreement |  |  | 60.0 |
Collaborative Arrangement With N B E Therapeutics |  |  |  |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |  |  |  |
Collaborative agreements upfront payments |  |  | $ 25.0 |
Collaboration and license agreement target selection term |  |  | 2 years |
Collaboration and license agreement extended target selection term |  |  | 3 years |
Collaboration agreements additional upfront payments |  |  | $ 2.0 |
Collaboration agreement option exercise fee payment, upon exercising option |  |  | 10.0 |
Maximum amount eligible for development and regulatory milestones |  |  | 90.0 |
Maximum amount eligible for commercial milestones under collaborations agreement |  |  | $ 135.0 |
Extension option term |  |  | 18 months |
Collaboration Agreement With Aurigene Discovery Technologies Limited Collaboration Agreement |  |  |  |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |  |  |  |
Maximum amount eligible for development and regulatory milestones | $ 148.8 |  |  |
Collaboration agreement, number of programs | program | 6 |  |  |
Upfront payments | $ 17.5 |  |  |
Collaboration agreement pre-existing programs | program | 3 |  |  |
Potential development and regulatory milestone payments | $ 280.0 |  |  |
Collaboration Agreement With Aurigene Discovery Technologies Limited Collaboration Agreement | Maximum |  |  |  |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |  |  |  |
Collaboration agreement option exercise fee payment, upon exercising option |  |  |  | $ 12.0
Collaboration Agreement With Aurigene Discovery Technologies Limited Collaboration Agreement | Minimum |  |  |  |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |  |  |  |
Collaboration agreement option exercise fee payment, upon exercising option |  |  |  | 10.0
Collaboration Agreement With Iconic Therapeutics, Inc. |  |  |  |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |  |  |  |
Collaboration agreement option exercise fee payment, upon exercising option |  |  |  | 20.0
Maximum amount eligible for development and regulatory milestones |  |  |  | 190.6
Potential development and regulatory milestone payments |  |  |  | $ 262.5
Upfront payment |  | $ 7.5 |  |

X
- Definition Collaboration Agreement, Number Of Preexisting Programs + References No definition available. + Details
Name: | exel_CollaborationAgreementNumberOfPreexistingPrograms
Namespace Prefix: | exel_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | instant

X
- Definition Collaboration Agreement, Number Of Programs + References No definition available. + Details
Name: | exel_CollaborationAgreementNumberOfPrograms
Namespace Prefix: | exel_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | instant

X
- Definition Collaboration Agreement, Option Exercise Fee Payment, Upon Exercising Option + References No definition available. + Details
Name: | exel_CollaborationAgreementOptionExerciseFeePaymentUponExercisingOption
Namespace Prefix: | exel_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Collaboration Agreements Additional Upfront Payments + References No definition available. + Details
Name: | exel_CollaborationAgreementsAdditionalUpfrontPayments
Namespace Prefix: | exel_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Collaboration Agreements, Upfront Payments + References No definition available. + Details
Name: | exel_CollaborationAgreementsUpfrontPayments
Namespace Prefix: | exel_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Collaboration And License Agreement Extended Target Selection Term + References No definition available. + Details
Name: | exel_CollaborationAndLicenseAgreementExtendedTargetSelectionTerm
Namespace Prefix: | exel_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Collaboration And License Agreement, Target Selection, Extension Option Term + References No definition available. + Details
Name: | exel_CollaborationAndLicenseAgreementTargetSelectionExtensionOptionTerm
Namespace Prefix: | exel_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Collaboration And License Agreement Target Selection Term + References No definition available. + Details
Name: | exel_CollaborationAndLicenseAgreementTargetSelectionTerm
Namespace Prefix: | exel_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Collaborative Agreement, Maximum Amount Eligible For Commercial Milestones Under Collaborations Agreement + References No definition available. + Details
Name: | exel_CollaborativeAgreementMaximumAmountEligibleForCommercialMilestonesUnderCollaborationsAgreement
Namespace Prefix: | exel_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Collaborative Agreements Upfront Payments + References No definition available. + Details
Name: | exel_CollaborativeAgreementsUpfrontPayments
Namespace Prefix: | exel_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Maximum amount eligible for development and regulatory milestones under collaborations agreement. + References No definition available. + Details
Name: | exel_CollaborativeArrangementMaximumAmountEligibleForDevelopmentAndRegulatoryMilestones
Namespace Prefix: | exel_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Maximum amount eligible for commercial milestones under collaborations agreement. + References No definition available. + Details
Name: | exel_MaximumAmountEligibleForCommercialMilestonesUnderCollaborationsAgreement
Namespace Prefix: | exel_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Upfront Payment(s) + References No definition available. + Details
Name: | exel_UpfrontPayments
Namespace Prefix: | exel_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=exel_CollaborativeArrangementWithCatalentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=exel_CollaborativeArrangementWithNBETherapeuticsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=exel_CollaborationAgreementWithAurigeneDiscoveryTechnologiesLimitedCollaborationAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MinimumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=exel_CollaborationAgreementWithIconicTherapeuticsInc.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |